John J Stroman, the Executive Vice President of $BXP, sold 16,838 shares of the company on 11-12-2025 for an estimated $1,215,238. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $BXP stock.
$BXP Insider Trading Activity
$BXP insiders have traded $BXP stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BXP stock by insiders over the last 6 months:
- JOHN J STROMAN (Executive Vice President) sold 16,838 shares for an estimated $1,215,238
- MICHAEL E LABELLE (EVP and CFO) sold 13,422 shares for an estimated $970,951
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BXP Hedge Fund Activity
We have seen 303 institutional investors add shares of $BXP stock to their portfolio, and 295 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COHEN & STEERS, INC. added 3,172,545 shares (+163.1%) to their portfolio in Q2 2025, for an estimated $214,051,611
- NORGES BANK removed 2,514,963 shares (-19.8%) from their portfolio in Q2 2025, for an estimated $169,684,553
- BLACKROCK, INC. removed 1,704,290 shares (-8.7%) from their portfolio in Q3 2025, for an estimated $126,696,918
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 1,243,392 shares (-30.3%) from their portfolio in Q3 2025, for an estimated $92,433,761
- GOLDENTREE ASSET MANAGEMENT LP removed 1,087,212 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $73,354,193
- JPMORGAN CHASE & CO removed 1,034,593 shares (-26.0%) from their portfolio in Q3 2025, for an estimated $76,911,643
- NORTHERN TRUST CORP removed 885,631 shares (-21.2%) from their portfolio in Q2 2025, for an estimated $59,753,523
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BXP Analyst Ratings
Wall Street analysts have issued reports on $BXP in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 10/13/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/01/2025
- Piper Sandler issued a "Overweight" rating on 09/09/2025
- BMO Capital issued a "Outperform" rating on 09/09/2025
- Wells Fargo issued a "Overweight" rating on 08/27/2025
To track analyst ratings and price targets for $BXP, check out Quiver Quantitative's $BXP forecast page.
$BXP Price Targets
Multiple analysts have issued price targets for $BXP recently. We have seen 15 analysts offer price targets for $BXP in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Anthony Paolone from JP Morgan set a target price of $83.0 on 10/17/2025
- Joe Dickstein from Jefferies set a target price of $84.0 on 10/13/2025
- Richard Anderson from Cantor Fitzgerald set a target price of $90.0 on 10/01/2025
- Steve Sakwa from Evercore ISI Group set a target price of $77.0 on 09/29/2025
- Alexander Goldfarb from Goldman Sachs set a target price of $76.0 on 09/11/2025
- Michael Lewis from Truist Securities set a target price of $77.0 on 09/10/2025
- Nick Joseph from Citigroup set a target price of $75.0 on 09/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
